Clinical usefulness of markers in monitoring patients with cancer.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis; D006063:Chorionic Gonadotropin / Q000032:analysis; D004407:Dysgerminoma / Q000175:diagnosis; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D007177:Inappropriate ADH Syndrome / Q000209:etiology; D008113:Liver Neoplasms / Q000175:diagnosis; D008297:Male; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism; D013736:Testicular Neoplasms / Q000175:diagnosis; D000509:alpha-Fetoproteins / Q000032:analysis
D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins; D000324:Adrenocorticotropic Hormone